ClinicalTrials.govpublic full text
Bevacizumab in Treating Patients With Relapsed or Refractory Multiple Myeloma
multiple myeloma and plasma cell neoplasm, refractory multiple myeloma, stage i multiple myeloma, stage ii multiple myeloma, stage iii multiple myeloma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 981684
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.